We are delighted to announce that Clare Foy (Director – Global Market Access), Hannah Palin (Director – Local Market Access), and Calum Jones (Associate Director – Health Economics) will be...
Read More
Global healthcare faces growing pressures. We explore how HEOR is evolving in 2025 to deliver value, meet payer needs, and support market access decisions.
Are you unsure about some of the terminology used by specialists who are preparing your evidence dossier? Here our experts answer some of the most frequently asked questions about systematic literature reviews and network meta-analysis.
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
We’re delighted to announce that we will be exhibiting at ISPOR Europe in Barcelona over the 18th–20th November 2024. Mtech Access experts will be joined by our colleagues from across Petauri, including...
Read More
Alex Hodkinson recently joined Mtech Access as Consultant – Statistician in our evidence synthesis team. In this interview, we learn about his career to date and what inspired him to join Mtech Access. Alex also shares some of his experiences since joining the team.
What’s involved in conducting a systematic review? Our evidence experts outline the 7 stages for developing a HTA-ready gold-standard systematic literature review.
Hayley Shoel shares her experience of joining Mtech Access’ specialist medical writing team. Explore the different types of projects she’s working on. Discover what you could expect if you joined us at Mtech Access.
Rachel Hibbs (Consultant – Systematic Review) tells us about her career to date and what inspired her to join Mtech Access.
We bring together specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024-25. Jump in, as our experts give their hot-take on each trend, sharing their perspectives on what’s happening in these areas.
